| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $587.9M | +50.6% |
| Cost of Revenue | $119.6M | +32.2% |
| Gross Profit | $468.2M | +56.1% |
| R&D Expense | $368.1M | +265.1% |
| SG&A Expense | $329.5M | +415.5% |
| Operating Income | -$546.4M | -1612.2% |
| Pre-tax Income | -$527.3M | -4584.3% |
| Income Tax | $998K | +47.4% |
| Net Income | -$528.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $208.0M | -30.8% |
| Accounts Receivable | $66.1M | +55.5% |
| Inventory | $15.6M | +43.8% |
| Current Assets | $533.9M | -8.5% |
| Total Assets | $744.8M | +10.6% |
| Current Liabilities | $362.4M | +45.4% |
| Total Liabilities | $366.2M | +42.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $171.4M | +249.9% |
| Capital Expenditures | $708K | -31.9% |
| Investing Cash Flow | -$113.8M | -721.2% |
| Financing Cash Flow | -$150.5M | -6733.2% |
| Free Cash Flow | $170.7M | +256.0% |
| -4326.9% |
| EPS (Basic) | -$7.77 | -783.0% |
| EPS (Diluted) | -$7.77 | -783.0% |
| Stockholders' Equity |
| $178.7M |
| +141.1% |